Moreover, ML-385 inhibits the PI3K–mTOR (Phosphoinositide 3-kinase—Mammalian Target of Rapamycin) signaling pathway in lung squamous cell carcinoma [28]. Here, MTOR is linked to squamous cell lung carcinoma.